These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10364046)

  • 1. Photoallergic skin reaction to ribavirin.
    Stryjek-Kaminska D; Ochsendorf F; Röder C; Wolter M; Zeuzem S
    Am J Gastroenterol; 1999 Jun; 94(6):1686-8. PubMed ID: 10364046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders.
    Hasan F; Asker H; al Shamali M; al Kalaoui M; al Nakib B
    Hepatogastroenterology; 2000; 47(36):1642-4. PubMed ID: 11149023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C.
    Pol S; Nalpas B; Bourlière M; Couzigou P; Tran A; Abergel A; Zarski JP; Berthelot P; Bréchot C
    Hepatology; 2000 Jun; 31(6):1338-44. PubMed ID: 10827161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High initial dose combination regimen with interferon-alpha and ribavirin in chronic hepatitis C.
    Kotzev I; Ivanova I; Atanassova M; Atanassova A; Glinkova V; Gancheva D; Shalev I; Manevska B; Krasnaliev I; Tomcheva S
    Hepatogastroenterology; 2003; 50(50):463-6. PubMed ID: 12749248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
    Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P
    Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone.
    Milella M; Santantonio T; Pietromatera G; Maselli R; Casalino C; Mariano N; Genchi C; Pastore G
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):211-5. PubMed ID: 10379482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photosensitive drug eruption induced by flutamide.
    Yokote R; Tokura Y; Igarashi N; Ishikawa O; Miyachi Y
    Eur J Dermatol; 1998 Sep; 8(6):427-9. PubMed ID: 9729061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photosensitivity induced by quinidine sulfate: experimental reproduction of skin lesions.
    Schürer NY; Hölzle E; Plewig G; Lehmann P
    Photodermatol Photoimmunol Photomed; 1992 Apr; 9(2):78-82. PubMed ID: 1489721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenofibrate-induced lichenoid photodermatitis.
    Gardeazabal J; Gonzalez M; Izu R; Gil N; Aguirre A; Diaz-Perez JL
    Photodermatol Photoimmunol Photomed; 1993 Aug; 9(4):156-8. PubMed ID: 8318433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phototoxic and photoallergic potential of tazarotene foam 0.1% in 2 phase 1 patch studies.
    Hogan DJ; Saenz AB
    Cutis; 2012 Nov; 90(5):266-71. PubMed ID: 23270200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of reactive intermediates in photoallergic dermatitis.
    Andreu I; Mayorga C; Miranda MA
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):303-8. PubMed ID: 20585243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced solar urticaria due to repirinast.
    Kurumaji Y; Shono M
    Dermatology; 1994; 188(2):117-21. PubMed ID: 8136537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phototoxicity and photoallergy].
    Selvåg E
    Nord Med; 1998 Dec; 113(10):335-7. PubMed ID: 9894409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.